 |
市场调查报告书
商品编码
1608866
癌症单株抗体市场：按来源、按应用、按最终用户、按地区Cancer Monoclonal Antibodies Market, By Source, By Application, By End User, By Geography |
||||||
癌症单株抗体市场预计到2024年将达到966.8亿美元，预计到2031年将达到2,631.7亿美元，2024年至2031年的复合年增长率为15.4%。
| 报告范围 | 报告详情 | ||
|---|---|---|---|
| 基准年 | 2023年 | 2024年市场规模 | 966.8亿美元 |
| 实际资料 | 2019-2023 | 预测期 | 2024年至2031年 |
| 预测 2024-2031 年复合年增长率： | 15.40% | 2031 年金额预测 | 2631.7亿美元 |
癌症单株抗体是人工产生的蛋白质，能够辨识癌细胞并与其自身结合。这些抗体由製药公司商业性开发，用于识别和击败人体内的癌细胞，而不伤害正常细胞。抗体与癌细胞表面的特定分子结合，帮助人体的免疫系统选择性地辨识和攻击癌细胞。由于癌症发病率的增加、新抗体药物的研发进展以及更容易患癌症的老年人口的增加，全球癌症单株抗体市场近期出现了显着的趋势。
市场动态：
2022年5月，世界卫生组织预计，到2040年，癌症新增病例数预计将达到2,700万，癌症死亡人数将达1,630万。另一个市场驱动力是持续的研究和开发，导致发现新型单株抗体药物和针对各种癌症类型的联合治疗，从而改善患者的治疗结果。然而，单株抗体药物的高成本是其广泛使用的主要阻碍因素。严格的法规和漫长的产品核可时间加剧了挑战。市场抓住了医疗保健支出不断增加的新兴国家带来的利润丰厚的机会。
本研究的主要特点
该报告对全球癌症单株抗体市场进行了详细分析，并提供了以2023年为基准年的预测期（2024-2031）的市场规模和年复合成长率（CAGR%）。
它还揭示了各个细分市场的潜在商机，并说明了该市场有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
根据公司亮点、产品系列、主要亮点、绩效和策略等参数对全球癌症单株抗体市场的主要企业进行了分析。
本研究涵盖的主要企业包括 Abnova Corporation、BioGenex、Bio-Rad Laboratories, Inc.、AMSBIO、Elabscience Bionovation Inc.、Fortis Life Sciences、Creative Diagnostics、Rockland Immunochemicals, Inc.、GenScript、Leinco Technologies、Abcam Limited、Sino Biological 、公司等
该报告的见解使负责人和公司经营团队能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
全球癌症单株抗体市场报告针对该行业的各个相关人员相关者，如投资者、供应商、产品製造商、分销商、新进业者和财务分析师。
透过用于分析全球癌症单株抗体市场的各种策略矩阵，将有助于相关人员做出决策。
目录
第一章 研究目的与前提
- 研究目的
- 先决条件
- 简称
第二章 市场展望
- 报告说明
- 市场定义和范围
- 执行摘要
第三章市场动态、法规及趋势分析
- 市场动态
- 影响分析
- 主要亮点
- 监管场景
- 产品发布/核准
- PEST分析
- 波特分析
- 併购场景
- 市场趋势
- 主要进展
第四章癌症单株抗体市场，依来源划分，2019-2031
- 人类
- 嵌合体
- 鼠
- 人性化
第五章癌症单株抗体市场，依应用划分，2019-2031
- 血癌
- 乳癌
- 肺癌
- 大肠直肠癌
- 肝癌
- 其他的
第六章癌症单株抗体市场，依最终用户划分，2019-2031
- 医院
- 临床和诊断实验室
- 研究所
- 其他的
第七章2019-2031年全球癌症单株抗体市场（按地区）
- 北美洲
- 拉丁美洲
- 欧洲
- 亚太地区
- 中东
- 非洲
第八章 竞争格局
- Abnova Corporation
- BioGenex
- Bio-Rad Laboratories, Inc.
- AMSBIO
- Elabscience Bionovation Inc.
- Fortis Life Sciences
- Creative Diagnostics
- Rockland Immunochemicals, Inc.
- GenScript
- Leinco Technologies
- Abcam Limited
- Sino Biological, Inc.
第九章 分析师建议
- 命运之轮
- 分析师观点
- 一致的机会图
第10章 参考文献与调查方法
- 参考
- 调查方法
- 关于出版商
The cancer monoclonal antibodies market is estimated to be valued at USD 96.68 Bn in 2024 and is expected to reach USD 263.17 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 15.4% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | 96.68 Bn |
| Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2024 to 2031 CAGR: | 15.40% | 2031 Value Projection: | 263.17 Bn |
Cancer monoclonal antibodies are artificially created proteins that have the capability to identify and bind themselves to cancer cells. These antibodies are commercially developed by pharmaceutical companies to identify and overcome cancer cells in the human body without harming normal cells. They work by attaching themselves to specific molecules found on cancer cell surfaces and helping the body's own immune system to recognize and attack those cancer cells selectively. The global cancer monoclonal antibodies market has witnessed tremendous growth in recent years due to the increasing prevalence of cancer, ongoing research, and development leading to novel antibody drugs and the growing geriatric population which is more prone to cancer.
Market Dynamics:
The global cancer monoclonal antibodies market growth is driven by the rising incidence of cancer worldwide owing to factors like increasing tobacco consumption, exposure to carcinogenic substances, changing lifestyle patterns, and growing elderly population. in May 2022, as per the WHO estimates, cancer burden is expected to reach 27 million new cases and 16.3 million cancer deaths by 2040. Another major market growth driver is the ongoing research and development leading to the discovery of novel monoclonal antibody drugs and combination therapies for various cancer types which has improved patient outcomes. However, high costs associated with monoclonal antibody drugs acts as a major restraint for widespread adoption. Also, stringent regulatory policies and lengthy product approval process adds to the challenges. The market sees lucrative opportunities arising from emerging economies with growing healthcare expenditures.
Key Features of the Study:
This report provides in-depth analysis of the global cancer monoclonal antibodies market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global cancer monoclonal antibodies market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Abnova Corporation, BioGenex, Bio-Rad Laboratories, Inc., AMSBIO, Elabscience Bionovation Inc., Fortis Life Sciences, Creative Diagnostics, Rockland Immunochemicals, Inc., GenScript, Leinco Technologies, Abcam Limited, and Sino Biological, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global cancer monoclonal antibodies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cancer monoclonal antibodies market
Market Segmentation
- By Source Insights (Revenue, USD Bn, 2019 - 2031)
- Human
- Chimeric
- Murine
- Humanized
- By Application Insights (Revenue, USD Bn, 2019 - 2031)
- Blood Cancer
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Liver Cancer
- Others
- By End User Insights (Revenue, USD Bn, 2019 - 2031)
- Hospital
- Clinical and Diagnostic Laboratories
- Research Institutes
- Others
- Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Abnova Corporation
- BioGenex
- Bio-Rad Laboratories, Inc.
- AMSBIO
- Elabscience Bionovation Inc.
- Fortis Life Sciences
- Creative Diagnostics
- Rockland Immunochemicals, Inc.
- GenScript
- Leinco Technologies
- Abcam Limited
- Sino Biological, Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Cancer Monoclonal Antibodies Market, By Source
- Cancer Monoclonal Antibodies Market, By Application
- Cancer Monoclonal Antibodies Market, By End User
- Cancer Monoclonal Antibodies Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Market Trends
- Key Developments
4. Cancer Monoclonal Antibodies Market, By Source, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Human
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Chimeric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Murine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Humanized
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
5. Cancer Monoclonal Antibodies Market, By Application, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Blood Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Breast Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Lung Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Colorectal Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Liver Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Cancer Monoclonal Antibodies Market, By End User, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Hospital
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Clinical and Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Cancer Monoclonal Antibodies Market, By Region, 2019 - 2031, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Source, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Source, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Source, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Source, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Source, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Source, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- Abnova Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BioGenex
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio-Rad Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AMSBIO
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Elabscience Bionovation Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Fortis Life Sciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Creative Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Rockland Immunochemicals, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GenScript
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Leinco Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abcam Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sino Biological, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
9. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us
癌症单株抗体市场规模、份额和成长分析（按类型、应用、最终用户和地区）：产业预测（2024-2031）
癌症单株抗体市场：按类型、应用和最终用户划分 - 全球预测 2025-2030
全球癌症单株抗体市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测
2024-2032 年按抗体类型、药物类型（贝伐单抗、利妥昔单抗、曲妥珠单抗、西妥昔单抗、帕尼单抗等）、应用、最终用户和地区分類的癌症单株抗体市场报告
癌症单株抗体市场报告：2030 年趋势、预测与竞争分析
癌症单株抗体市场 - 2018-2028 年全球产业规模、份额、趋势、机会和预测，按单株抗体类型、单株抗体疗法、按应用、地区、竞争细分
癌症单克隆抗体市场：按抗体类型、应用、最终用户分类：2021-2031 年全球机遇分析和行业预测